Phase 1 Advanced Tumors Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Study of CS23546 in Subjects With Advanced Tumors
Advanced Tumors
Chipscreen Biosciences, Ltd.156 enrolled1 locationNCT06245122
Recruiting
Phase 1Phase 2
Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors
Advanced Tumors
ModeX Therapeutics, An OPKO Health Company235 enrolled6 locationsNCT07110584
Recruiting
Phase 1
A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.
Advanced Tumors
Shanghai Institute Of Biological Products160 enrolled1 locationNCT07205198
Recruiting
Phase 1
A Study of AL58805 in Patients With Advanced Tumors
Advanced Tumors
Advenchen Laboratories Nanjing Ltd.40 enrolled1 locationNCT07179081